Abstract
The conducting airways are the primary target for gene transfer in cystic fibrosis (CF), yet the inflammation associated with CF lung disease could potentially pose a significant barrier to gene transfer vectors, such as recombinant adeno-associated virus (rAAV). In order to investigate this possibility, aliquots of bronchoalveolar lavage (BAL) fluid from eight individuals with CF were tested for their in vitro inhibitory effects on rAAV transduction, along with BAL from non-CF individuals. While the non-CF BAL fluid was not inhibitory, seven of eight CF BAL samples had significant inhibitory activity, resulting in a five- to 20-fold reduction in transduction events. Inhibition of rAAV transduction by CF BAL could be reversed by alpha-1-antitrypsin (AAT), but not by DNase. When neutrophil elastase and neutrophil alpha defensins (human neutrophil peptides, HNP) were measured in these samples, they were elevated by 500- and 10000-fold, respectively. The levels of HNP correlated inversely with the amount of rAAV transduction. Furthermore, rAAV transduction could be blocked by purified HNP in an AAT-reversible manner at HNP concentrations within the range measured in these fluids. We conclude that products of inflammation in CF BAL fluid are inhibitory to rAAV transduction, and that these effects may be reversible by AAT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stern M et al. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro Gene Therapy 1998 5: 91–98
Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector Proc Natl Acad Sci USA 1993 90: 10613–10617
Flotte TR et al. A fluorescence video-endoscopy technique for detection of gene transfer and expression Gene Therapy 1998 5: 166–173
Afione SA et al. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure J Virol 1998 72: 9795–9805
Afione SA et al. In vivo model of adeno-associated virus vector persistence and rescue J Virol 1996 70: 3235–3241
Conrad CK et al. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung Gene Therapy 1996 3: 658–668
Wagner JA et al. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus (letter) Lancet 1998 351: 1702–1703
Flotte T et al. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease Hum Gene Ther 1996 7: 1145–1159
Summerford C, Samulski RJ . Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions J Virol 1998 72: 1438–1445
Shwachman H, Kulczycki LL . Long term study of one hundred and five patients with cystic fibrosis Am J Dis Child 1958 96: 6–15
van Heeckeren A, Ferkol T, Tosi M . Effects of bronchopulmonary inflammation induced by pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in mice Gene Therapy 1998 5: 345–351
Cantin AM . DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice Am J Respir Crit Care Med 1998 157: 464–469
Blacklow NR et al. A seroepidemiologic study of adenovirus-associated virus infection in infants and children Am J Epidemiol 1971 94: 359–366
Beck SE et al. Repeated delivery of adeno-associated virus (AAV) vectors to the rabbit airway J Virol 1999 73: 9446–9455
Halbert CL et al. Transducction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration J Virol 1997 71: 5932–5941
Eisenhauer P et al. Polymorphic expression of defensins in neutrophils from outbred rats Infect Immun 1990 58: 3899–3902
Kagan BL, Ganz T, Lehrer RI . Defensins: a family of antimicrobial and cytotoxic peptides Toxicology 1994 87: 131–149
Lehrer RI, Ganz T, Szklarek D, Selsted ME . Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations J Clin Invest 1988 81: 1829–1835
Zolotukhin S et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield Gene Therapy 1999 6: 973–985
Konstan MW, Hilliard KA, Norvell TM, Berger M . Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation (published erratum appears in Am J Respir Crit Care Med 1995 Jan; 151(1): 260) Am J Respir Crit Care Med 1994 150: 448–454
Zolotukhin S et al. A ‘humanized’ green fluorescent protein cDNA adapted for high-level expression in mammalian cells J Virol 1996 70: 4646–4654
Zeitlin PL et al. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection Am J Respir Cell Mol Biol 1991 4: 313–319
Fruhwirth M et al. Flow-cytometric evaluation of oxidative burst in phagocytic cells of children with cystic fibrosis Int Arch Allergy Immunol 1998 117: 270–275
Acknowledgements
This work was supported by grants from NIH (HL51811, RR0082, DK51809). The original study from which the discard BAL was obtained was sponsored by Targeted Genetics Corporation. Many thanks to Margaret Humphries for help with study coordination and to Thomas Ferkol and Barrie Carter for advice that helped to guide these studies.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Virella-Lowell, I., Poirier, A., Chesnut, K. et al. Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther 7, 1783–1789 (2000). https://doi.org/10.1038/sj.gt.3301268
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301268
Keywords
This article is cited by
-
Strategy to detect pre-existing immunity to AAV gene therapy
Gene Therapy (2017)
-
Overcoming the Cystic Fibrosis Sputum Barrier to Leading Adeno-associated Virus Gene Therapy Vectors
Molecular Therapy (2014)
-
Adeno-associated virus serotype 9-mediated pulmonary transgene expression: effect of mouse strain, animal gender and lung inflammation
Gene Therapy (2011)
-
In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors
Gene Therapy (2010)
-
Gene Therapy for Cystic Fibrosis
Clinical Reviews in Allergy & Immunology (2008)